A phase 2, proof-of-concept, placebo-controlled, randomized, multicenter, double-blind study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of Usnoflast (ZYIL1) in patients with amyotrophic lateral sclerosis
1. 系统已在2025-10-31 15:39:38对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1080/21678421.2025.2515900
文献链接: https://www.tandfonline.com/doi/full/10.1080/21678421.2025.2515900
其他信息:
出版社: Informa UK Limited
作者: Amit Yeole; Laxmi Khanna; Maulik Doshi; Arvind Sharma; Pratik Uttarwar; Suyog Doshi; Rana Kaushik Kumar; N. Venkataramana; Deven Parmar

